May 6th 2025
In comparison to American Joint Committee on Cancer (AJCC) TNM staging, an emerging CT-based scoring system for assessing early recurrence of pancreatic ductal adenocarcinoma demonstrated over a 22 percent higher AUC in testing and external validation cohorts in a new study.
Can EHR Interventions Have an Impact in Conserving Iodinated Contrast Media in Radiology?
August 3rd 2022A recent study found the use of an alert and a request for more clinical information in a multisite health system’s electronic health record (EHR) system led to a 12 percent reduction in contrast-enhanced computed tomography (CT) exams per day and a 15.2 percent reduction in orders for CT with contrast media per day.
Iodinated Contrast Media Alternative: FDA OKs Bayer Importing Foreign-Labeled Iopromide
July 19th 2022The Food and Drug Administration (FDA) has given the green light to Bayer to import foreign-labeled iopromide (Ultravist) to help alleviate ongoing supply challenges with iodinated contrast media in the United States.
Study Confirms Higher Accuracy of MRI Over Emerging PSMA PET/CT for Diagnosing Prostate Cancer
July 8th 2022Magnetic resonance imaging (MRI) had better accuracy than prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) “for detecting any grade of prostate cancer,” according to new study findings presented at the European Association of Urology Annual Congress (EAU22) in Amsterdam.
CMS Declines to Expand Coverage of Computed Tomography Colonography (CTC) for Medicare Beneficiaries
July 7th 2022Citing “insufficient” evidence, the Centers for Medicare and Medicaid Services (CMS) has declined a formal request by the American College of Radiology and multiple patient advocacy groups to reevaluate the lack of Medicare and Medicaid coverage of computed tomography colonography (CTC) for colorectal cancer screening.
Philips Adds Proteomic Nodule Risk Assessment to Lung Cancer Orchestrator System
June 30th 2022The addition of Biodesix’s Nodify Lung nodule risk assessment tool to Philips’ lung cancer patient management system may enhance diagnostic efficiency and facilitate improved management of high-risk patients.
Colorectal Cancer Screening: Could a Lower Age Threshold Reveal Greater Screening Disparities?
June 30th 2022In a large study looking at the use of colorectal cancer screening techniques (including computed tomography (CT) colonography) between 2000 and 2018, researchers found that the 50 to 54 age group had the lowest increases in screening and a significantly higher chasm of racial and socioeconomic disparities in comparison to other age groups.
AI Software Facilitates 22.1 Percent Reduction in Chest CT Review Time
June 17th 2022Noting that an AI software platform could save radiologists up to an hour a day in interpreting chest computed tomography (CT) scans, the authors of a prospective study found shorter mean interpretation times with non-contrast and contrast-enhanced CT as well as positive CT scans with and without significant new findings.
Siemens Healthineers Get FDA Nod for New SPECT/CT Scanner
June 12th 2022The newly FDA-cleared Symbia Pro.specta SPECT/CT Scanner, which reportedly offers a variety of enhanced capabilities including low-dose CT up to 64 slices and intuitive workflow guides, was launched at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2022 Annual Meeting.
Study Suggests the COVID-19 Pandemic Led to Millions of Decreased Cancer Screenings
June 6th 2022A new survey study from the American Cancer Society shows a 4.47 million decrease in cervical cancer screenings and a 2.13 million decrease in breast cancer screenings in the United States between 2018 and 2020.
Can Diffusion-Weighted MRI Have an Impact in Detecting Recurrent Pancreatic Cancer?
May 29th 2022For post-op monitoring of patients who had pancreatic ductal adenocarcinoma (PDAC) resection, a new study showed that diffusion-weighted magnetic resonance imaging (MRI) had enhanced sensitivity for detecting recurrent tumors in comparison to conventional MRI.